More than 30% of dental prostheses fitted in France now arrive from China, according to the National Union of Dental Prosthetists (UNPPD).
Price caps drive shift to foreign prostheses
The rise of foreign dental prostheses stems directly from a major regulatory overhaul implemented in 2021. The "100% Health" reform capped the prices that dental practitioners could charge patients for a wide range of common treatments and appliances.
Faced with strict price ceilings, dental clinics and mutual insurance networks faced an immediate financial squeeze. To preserve profit margins, many turned to international manufacturing hubs where labor costs are a fraction of those in France. It is estimated that producing a ceramic dental crown in China can cost up to eight times less than producing the same item in France.
While a French dental laboratory typically charges around 120 euros for a single tooth, the same prosthesis imported from China often costs approximately 40 euros. This staggering price gap made foreign manufacturing an attractive option for large-scale health networks and cost-driven dental practices.
French dental laboratories close amid foreign competition
The economic fallout for domestic artisans has been severe. The UNPPD estimates that nearly 1,000 French dental laboratories have permanently closed their doors over the past five years due to mounting foreign competition.
Traditional workshops struggle to match the sheer volume of overseas mass production. Arthur Zarakolu, co-manager of the AZM Laboratory in Paris, noted the stark disparity in output. His Paris workshop employs skilled technicians who spend a full day or two meticulously crafting a single piece—producing roughly 10,000 prostheses per year. By contrast, an industrial overseas facility can match an entire year of a Parisian workshop’s output in a single week.
Prosthetists argue that this competition is fundamentally unfair, noting that the combination of capped reimbursement rates in France and low production costs abroad leaves domestic workers with little room to compete.
Vyv 3 dismisses surgeons over sourcing quotas
The commercial divide erupted into an employment crisis when major health networks began enforcing foreign sourcing targets. Last month, the mutual insurance group Vyv 3 dismissed five dental surgeons from a clinic in Nantes after they refused to meet an internal quota requiring them to use at least 30% Chinese-made prostheses.
The dismissals resulted in the immediate closure of the clinic. Dentists who spoke out against the quotas argued that forcing patients to receive imported devices—often without their explicit knowledge—violates medical ethics, particularly since patients are billed the same standard rates regardless of where the hardware was manufactured.
Defending its practices, the Vyv 3 group stated that all international partners meet required regulatory standards. However, critics maintain that the push for cheaper materials compromises transparency and undermines the doctor-patient relationship.
Overseas facilities lack regular safety inspections
Beyond the economic and employment disputes, the reliance on imported medical devices raises regulatory concerns. Industry leaders point to a significant oversight gap between domestic and foreign manufacturing facilities.
Laurent Munerot, president of the UNPPD, highlighted the disparity in inspections, noting that the French Agency for Safety of Medicines regularly inspects local laboratories to verify the compliance of raw materials like ceramic and resin. Regulatory authorities rarely, if ever, conduct on-site inspections of overseas facilities in China.
Reports of cobalt usage in certain imported components have heightened anxieties regarding long-term biocompatibility and patient safety. While imported medical devices must technically clear regulatory approval processes, professional bodies argue that enforcement at origin remains weak.
Patient Awareness and Public Reaction
Most patients remain entirely unaware of where their dental crowns or bridges were manufactured. When informed about the prevalence of imported prostheses, consumer reactions lean strongly toward domestic preference.
Residents in Paris expressed skepticism regarding foreign medical components, citing a lack of quality transparency and a strong desire to support local manufacturing. Despite the potential for lower upfront costs or identical reimbursement rates, consumers voiced a clear preference for domestically produced healthcare products.
Questions About Dental Prostheses Imports
How many dental prostheses in France come from China?
Industry estimates from the UNPPD indicate that over 30% of all dental prostheses fitted in France are manufactured in China, with projections suggesting that figure could reach 50% by 2030.
Why did the use of foreign dental prostheses accelerate in 2021?
The surge followed the implementation of the "100% Health" reform in France, which capped prices for numerous dental procedures and forced practitioners to seek lower-cost manufacturing options to maintain profit margins.
What happened to the dentists in Nantes?
The Vyv 3 mutual insurance group dismissed five dental surgeons from a clinic in Nantes for refusing to meet an internal quota requiring them to use at least 30% Chinese-manufactured prostheses, leading to the clinic’s closure.
Do patients know if their dental prosthesis is imported?
In most cases, patients are not informed of the geographic origin of their dental prostheses, as they are billed standard rates and receive the same level of insurance reimbursement regardless of where the item was manufactured.
Keep reading